Archives

纳伦德拉 莫迪作为的印度新总理应该视为西方医学公司的好兆头。作为前古吉拉特邦首席部长，古吉拉特邦在莫迪的政策领导下，表现出可观的经济增长。他总理的当选，在很大程度上是因为他承诺，他将推动整个印度的经济增长。 Read More

Economic growth in Asia will be almost 6% in 2014 (excluding Japan), compared with 1.5% in the EU and 2.5% in the U.S. Asia's growth will be led by China, which is expected to expand over 7% this year. The economies of... Read More

The election of Narendra Modi as Prime Minister of India should bode well for Western medical companies. As Chief Minister of Gujarat, Modi's policies led to considerable economic growth and development in the province. He was elected Prime Minister in large part... Read More

In India, a medical device registration certificate (Form 41) is valid for 3 years from the date of issue. Applications for re-registration should be submitted 9 months before the registration certificate expires. Recently, the Indian government has been focusing more on post... Read More

Worldwide, the home healthcare market -- including devices, services and related products -- is valued at more than $215 billion. This homecare market is expected to maintain growth rates of 8% annually through 2020. In Asia, an expanding middle class combined with... Read More

在印度，医疗器械注册证书（表格41）有效期为自签发之日起3年有效. 应在医疗器械注册证书到期9个月之前申请产品重新注册. 近日，印度政府更加注重上市后监督对重新登记的影响. 在印度上市后医疗器械不良事件，及其处理措施需要仔细记录. 最新的印度标签标准还要求企业提供1-800或免费电话号码队产品进行投诉. Read More

世界范围内，家庭医疗保健市场 - 包括医疗设备，服务及相关产品的价值超过$2150亿美元。在亚洲，一直到2020年，这个家庭护理市场有望每年保持8％的增长率。日益壮大的中产阶级结以及家庭护理的知识越来越多地积累，导致了基于家庭的服务和产品的需求迅速增长。预计2017年，亚洲家庭护理设备的销售（不包括其他家庭卫生产品或服务）将达到150亿美元，是2011年的8倍。 Read More

In Asia, rising patient awareness of homecare and an expanding middle class mean that demand for home healthcare is exploding. The Asian market for home healthcare products and services has a double digit annual growth rate. The Asian healthcare device market segment... Read More

The Indian medical device market is worth about $4.3 billion dollars. It is expected to grow to about $12 billion dollars by 2022. More and more Western device companies are registering their products in India. For registration renewals, the DCGI is now... Read More

The Indian government has allowed pharmaceutical companies to raise the maximum retail prices (MRPs) for drugs. Pursuant to the Drug Price Control Order (DPCO) 2013, essential medicine prices are capped at the average increase of all drugs in a certain segment that... Read More